Benfotiamine: High Bioavailability Fat-Soluble Vitamin B1 from China Suppliers & Factory
Benfotiamine is a lipid-soluble derivative of vitamin B1 that boasts superior bioavailability and bioactivity—approximately 3.6 times greater than that of standard water-soluble vitamin BThis unique formulation significantly enhances the absorption and effectiveness of vitamin B1, making it an excellent choice for those seeking improved health benefits. As a top choice among health-conscious consumers, our benfotiamine product is sourced from reliable China suppliers and manufactured in our state-of-the-art factory, ensuring quality and efficacy. Discover the advantages of benfotiamine today and elevate your wellness routine!
As a synthetic derivative of vitamin B1 (thiamine), benfotiamine significantly surpasses ordinary vitamin B1 in bioavailability, targeting and clinical efficacy through structural optimization and pharmacokinetic improvement. The specific advantages are as follows:
1
Structural Innovation: Lipid-Soluble Modification Breaks Through Absorption Limitations
Ordinary vitamin B1 (thiamine) is a water-soluble molecule that relies on intestinal sodium-dependent carriers (ThTr1/2) for active transport. It has a low absorption rate (<5%) and is easily saturated. High doses are easily excreted.
Benfotiamine is converted into a lipid-soluble prodrug by introducing benzoyl and phosphate groups (structural formula C19H23N4O6PS), which can bypass carrier restrictions and directly penetrate intestinal mucosal cells through passive diffusion.
>80%Absorption Efficiency
3–5×Bioavailability vs. Ordinary B1
<5%Ordinary B1 Absorption Rate
Reference: J Clin Pharmacol, 2008
2
Pharmacokinetic Advantages: Long-Term Effect and Tissue Targeting
Ordinary B1 has a short half-life in the blood (about 3.5 hours) and is easily cleared quickly by the kidneys. Benfotiamine is hydrolyzed into active thiamine by phosphatase in the body and further converted into thiamine pyrophosphate (TPP). Its lipid solubility makes it easier to accumulate in the phospholipid layer of the cell membrane, prolonging the duration of action.
>6 hrsBenfotiamine Half-Life
3.5 hrsOrdinary B1 Half-Life
8–10×Blood-Brain Barrier Penetration vs. B1
Its ability to penetrate the blood-brain barrier and nerve sheath is 8–10 times that of ordinary B1, and it can effectively act on the central and peripheral nervous systems.
Reference: Neurochem Res, 2016
3
Metabolic Regulation: Multi-Target Inhibition of Glucotoxic Damage
In a hyperglycemic environment, ordinary B1 is difficult to effectively inhibit abnormal glucose metabolism pathways due to poor tissue permeability. Benfotiamine shows unique advantages through the following mechanisms:
Blocking AGEs Generation: Inhibiting hexosamine and polyol pathways, reducing the accumulation of advanced glycation end products (AGEs), and alleviating axonal damage in diabetic neuropathy. (Diabetes, 2010)
Anti-Inflammatory & Antioxidant: Downregulating the activity of NF-κB and TXNIP/NLRP3 inflammasomes, reducing inflammatory factors such as IL-6 and TNF-α, while enhancing glutathione reductase activity and alleviating oxidative stress.
Mitochondrial Protection: Restoring the function of pyruvate dehydrogenase complex (PDH), improving the efficiency of tricarboxylic acid cycle, and reducing lactic acid accumulation.
4
Clinical Efficacy: High-Dose Tolerance and Deep Repair
Ordinary B1 requires extremely high doses (≥300 mg/day) to treat diabetic neuropathy, but its efficacy is limited due to its absorption rate. Benfotiamine can stably increase tissue TPP concentration within the dose range of 150–600 mg/day.
+2.1 m/sNerve Conduction Velocity vs. Placebo
–40%VAS Pain Score Reduction
0Reports of Liver/Kidney Toxicity
Reference: Diabetes Care, 2005
5
Stability and Compatibility of Preparations
Benfotiamine is significantly more stable than ordinary B1 in an acidic environment (pH 2.0–4.0):
Compatible with a variety of multivitamins or drug preparations. Its lipid-soluble properties support the development of delivery systems such as nanoemulsions and liposomes, further improving the efficiency of targeted delivery.
?
Frequently Asked Questions
Q1
What makes benfotiamine different from regular vitamin B1 (thiamine)?
Benfotiamine is a lipid-soluble synthetic derivative of thiamine. Unlike regular vitamin B1, which relies on sodium-dependent carriers for absorption at a rate of less than 5%, benfotiamine bypasses these carriers and diffuses passively through intestinal mucosal cells, achieving absorption efficiency of over 80% and 3–5 times the bioavailability of ordinary B1.
Q2
How does benfotiamine support nerve health in diabetic patients?
Benfotiamine penetrates the blood-brain barrier and nerve sheath at 8–10 times the rate of ordinary B1. In clinical trials, it has been shown to significantly improve nerve conduction velocity by +2.1 m/s versus placebo and reduce pain scores (VAS) by up to 40%, making it an effective option for managing diabetic peripheral neuropathy.
Q3
How does benfotiamine help reduce blood sugar-related damage (glucotoxicity)?
Benfotiamine works through multiple mechanisms: it blocks the formation of advanced glycation end products (AGEs) by inhibiting the hexosamine and polyol pathways, reduces inflammation by downregulating NF-κB and TXNIP/NLRP3, and protects mitochondrial function by restoring pyruvate dehydrogenase complex (PDH) activity — all of which help combat glucose-induced cellular damage.
Q4
Is benfotiamine safe at high doses?
Yes. Clinical studies demonstrate that benfotiamine can be used safely within a dose range of 150–600 mg/day, with no reported cases of liver or kidney toxicity. In contrast, ordinary B1 requires doses of ≥300 mg/day to achieve similar therapeutic effects, with far less efficiency and greater risk of renal excretion before reaching target tissues.
Q5
How stable is benfotiamine compared to regular vitamin B1 in acidic conditions?
Benfotiamine is far more stable in acidic environments (pH 2.0–4.0), showing a degradation rate of less than 5%, compared to over 30% for regular vitamin B1 under the same conditions. This enhanced stability makes it better suited for formulation into multivitamin and pharmaceutical preparations.
Q6
What types of drug delivery systems are compatible with benfotiamine?
Thanks to its lipid-soluble nature, benfotiamine is compatible with a wide range of formulations including standard tablets, capsules, multivitamin complexes, as well as advanced delivery systems such as nanoemulsions and liposomes. These systems further enhance targeted delivery efficiency and therapeutic outcomes.
